Your browser doesn't support javascript.
loading
Anakinra as an agent to control hemophagocytic lymphohistiocytosis in Griscelli type 2.
Kim, Sara R; Kissoon-Larkin, Trisha; Horn, Biljana; Elder, Melissa.
Affiliation
  • Kim SR; Department of Pediatrics, University of Florida Shands Children's Hospital, Gainesville, Florida.
  • Kissoon-Larkin T; Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of Florida, Gainesville, Florida.
  • Horn B; Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of Florida, Gainesville, Florida.
  • Elder M; Department of Pediatrics, Division of Allergy, Immunology, & Rheumatology, University of Florida, Gainesville, Florida.
Pediatr Blood Cancer ; 66(12): e27997, 2019 12.
Article in En | MEDLINE | ID: mdl-31535456

Full text: 1 Database: MEDLINE Main subject: Piebaldism / Antirheumatic Agents / Lymphohistiocytosis, Hemophagocytic / Interleukin 1 Receptor Antagonist Protein / Primary Immunodeficiency Diseases Type of study: Etiology_studies / Prognostic_studies Limits: Humans / Infant / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Piebaldism / Antirheumatic Agents / Lymphohistiocytosis, Hemophagocytic / Interleukin 1 Receptor Antagonist Protein / Primary Immunodeficiency Diseases Type of study: Etiology_studies / Prognostic_studies Limits: Humans / Infant / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2019 Type: Article